Follow
  • About Us
  • Privacy Policy
  • US News
  • Europe
  • Asia
  • Africa
  • Latin America and the Caribbean
  • Canada
  • Indian subcontinent
  • Australia
  • Middle East
Outbreak News Today
BREAKING
  • H9N2 avian influenza case reported in Guangdong Province, China
  • Naegleria fowleri: Leaves of a traditional medicinal plant kills amoebae in lab studies
  • South Africa COVID-19 strain detected in Denmark
  • China reports 1st human H5N6 avian influenza case of 2021
  • Lyme disease funding: $16 million for the CDC
  • Outbreak News Radio
  • Interviews
  • Drugs and antibiotics
  • Vaccines
  • Research
  • Blogs
  • Write for us
TRENDING
  • US News
  • Latin America and the Caribbean
  • Animal diseases
Home » Headlines » Universal influenza vaccine: An NIAID priority

Universal influenza vaccine: An NIAID priority

by Press Release
February 28, 2018
Headlines, Vaccines
1 Comment

Developing a universal influenza vaccine — a vaccine that can provide durable protection for all age groups against multiple influenza strains, including those that might cause a pandemic — is a priority for the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Writing in the Journal of Infectious Diseases, NIAID officials detail the Institute’s new strategic plan for addressing the research areas essential to creating a safe and effective universal influenza vaccine. They describe the scientific goals that will be supported to advance influenza vaccine development. The strategic plan builds upon a workshop NIAID convened in June 2017 that gathered scientists from academia, industry and government who developed criteria for defining a universal influenza vaccine, identified knowledge gaps, and delineated research strategies for addressing those gaps.

 Influenza A virions Image/CDC
Influenza A virions
Image/CDC

Flu Vaccine Act introduced by Sen. Edward Markey: For the creation of a universal influenza vaccine

The cornerstone of both seasonal and pandemic influenza prevention and control is the development of vaccines against specific influenza strains that pose a potentially significant risk to the public. Seasonal influenza vaccines are made anew each year to best match the strains projected to circulate in the upcoming season. However, this approach has limitations and difficulties. To reduce the public health consequences of both seasonal and pandemic influenza, vaccines must be more broadly and durably protective. Advances in influenza virology, immunology and vaccinology make the development of a universal influenza vaccine more feasible than a decade ago, according to the authors. To develop a universal influenza vaccine, NIAID will focus resources on three key areas of influenza research: improving the understanding of the transmission, natural history and pathogenesis of influenza infection; precisely characterizing how protective influenza immunity occurs and how to tailor vaccination responses to achieve it; and supporting the rational design of universal influenza vaccines, including designing new immunogens and adjuvants to boost immunity and extend the duration of protection.

The authors state that a coordinated effort of guided discovery, facilitated product development and managed progress through iterative clinical testing will be critical to achieving the goal of a universal influenza vaccine. NIAID will establish and support a consortium of scientists to meet designated goals for a universal influenza vaccine and will expand the Institute’s research resources by establishing long-term human cohorts, supporting improved animal models of influenza infection and expanding capacity for conducting human challenge studies.

The authors emphasize that broad collaboration and coordination in many disciplines and involving government, academia, philanthropies and the private sector will be vital to achieving the goal of developing a universal influenza vaccine. NIAID intends for the plan to serve as the foundation for its research investment strategy to achieve this important public health goal.

 

One thought on “Universal influenza vaccine: An NIAID priority”

  1. Pingback: Universal Flu Vaccine: Senators ask NIAID for update | The Global Dispatch | The Global Dispatch

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

National Debt Relief is rated #1 for debt consolidation

Newsletter

Subscribe to our periodic Newsletter

* indicates required
The Place Where Movies Never Get Old

Outbreak News TV 1

blood shirt

Recent Posts

  • H9N2 avian influenza case reported in Guangdong Province, China
  • Naegleria fowleri: Leaves of a traditional medicinal plant kills amoebae in lab studies
  • South Africa COVID-19 strain detected in Denmark
  • China reports 1st human H5N6 avian influenza case of 2021
  • Lyme disease funding: $16 million for the CDC
  • China reports COVID-19 surge in Hebei province
  • South Africa COVID-19 variant in the UK identified, Travel restrictions
  • Philippines total COVID-19 cases near 500K, Promoting vaccinations among physicians
  • Peru reports worst dengue epidemic since 2017
  • Nigeria reaches the ‘100,000 cases milestone’
  • San Diego Zoo reports gorillas test positive for SARS-CoV-2
  • LexaGene to Detect UK and South African COVID Sequences
  • First case of the UK COVID-19 variant detected in Illinois
  • Lyme disease: ≈476,000 patients diagnosed annually from 2010–2018
  • Brazil Health Minister: ‘Our vaccination program for COVID-19 will be the largest in the world’
  • Vir Biotechnology & Gilead Announce Phase 2 Clinical Trial Collab for Functional Cure of Hepatitis B Virus
  • Philippines report 1st UK COVID-19 variant, 30 million doses of Covovax vaccine secured
  • Thailand reports 71,000 dengue cases in 2020
  • Peste des petits ruminants closer to eradication
  • Sweden reports 80K COVID-19 vaccinations administered
© Copyright Outbreak News Today

This website uses cookies to provide you with the best browsing experience.

Find out more or adjust your settings.

Outbreak News Today
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.